Brief: NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
27/05/2025 13:54
May 27 (Reuters) - Neuropace Inc NPCE.O: NEUROPACE INC: REAFFIRMS ITS PREVIOUSLY ISSUED FULL-YEAR 2025 FINANCIAL GUIDANCE NEUROPACE INC - COMPLETES PRIMARY ENDPOINT ANALYSIS FOR IDIOPATHIC GENERALIZED EPILEPSY STUDY NEUROPACE INC - STUDY MEETS 12-WEEK POST-IMPLANT SAFETY ENDPOINT NEUROPACE INC - PRELIMINARY DATA SHOWS FAVORABLE SEIZURE REDUCTION RATES FOR RNS SYSTEM NEUROPACE - PRIMARY EFFECTIVENESS ENDPOINT NOT STATISTICALLY SIGNIFICANT IN OVERALL POPULATION Source text: ID:nGNX8f1wL3 Further company coverage: NPCE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroPace
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
NeuroPace, Inc. reports results for the quarter ended June 30 - Earnings Summary
NeuroPace Q2 revenue slightly beats estimates
Brief: NeuroPace, Inc. Q2 EPS USD -0.18
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview